Subscribe To
THRD / Why Is Third Harmonic Bio (THRD) Stock Down 75% Today?
THRD News
By GlobeNewsWire
August 31, 2023
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wa more_horizontal
By Benzinga
February 3, 2023
Top 5 Health Care Stocks That May Rally - AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. more_horizontal
By InvestorPlace
December 15, 2022
Why Is Third Harmonic Bio (THRD) Stock Down 75% Today?
Long-term investors of Third Harmonic Bio (NASDAQ: THRD ) are feeling some discomfort today, to put it mildly. This morning, THRD stock is losing the more_horizontal
By Market Watch
December 15, 2022
Third Harmonic's stock falls 75% after discontinuing clinical trial
Shares of Third Harmonic Bio Inc. tumbled 75% in premarket trading on Thursday after the company said it discontinued the Phase 1b study of its treatm more_horizontal